# Citizens Financial Group Inc: overview

CFG · NYSE · CIK 759944 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cfg.md) · [Financials](/companies/cfg/financials.md) · [Filings](/companies/cfg/filings.md) · [Insiders](/companies/cfg/insiders.md)

Latest reported revenue: [$451.0m](/filings/0000759944-26-000148.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 3, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000759944-26-000148).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [367](/filings/0000759944-25-000153.md) | [397 d](/filings/0000759944-26-000028.md) | [367](/filings/0000759944-26-000101.md) | [383](/filings/0000759944-26-000148.md) | [452](/filings/0000759944-25-000153.md) | [433 d](/filings/0000759944-26-000028.md) | [415](/filings/0000759944-26-000101.md) | [451](/filings/0000759944-26-000148.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [104.1%](/filings/0000759944-25-000153.md) | [101.0% d](/filings/0000759944-26-000028.md) | [101.6%](/filings/0000759944-26-000101.md) | [113.8%](/filings/0000759944-26-000148.md) | [109.3%](/filings/0000759944-25-000153.md) | [121.9% d](/filings/0000759944-26-000028.md) | [124.6%](/filings/0000759944-26-000101.md) | [130.2%](/filings/0000759944-26-000148.md) |
| Diluted EPS | $ per share | [0.77](/filings/0000759944-25-000153.md) | not reported | [0.77](/filings/0000759944-26-000101.md) | [0.92](/filings/0000759944-26-000148.md) | [1.05](/filings/0000759944-25-000153.md) | not reported | [1.13](/filings/0000759944-26-000101.md) | [1.30](/filings/0000759944-26-000148.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,325](/filings/0000759944-24-000039.md) | [1,299](/filings/0000759944-25-000013.md) | [1,266](/filings/0000759944-26-000028.md) | [1,533](/filings/0000759944-26-000028.md) | [1,635](/filings/0000759944-26-000028.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [175.0%](/filings/0000759944-24-000039.md) | [159.6%](/filings/0000759944-25-000013.md) | [127.0%](/filings/0000759944-26-000028.md) | [98.4%](/filings/0000759944-26-000028.md) | [112.0%](/filings/0000759944-26-000028.md) |
| Diluted EPS | $ per share | [5.16](/filings/0000759944-24-000039.md) | [4.10](/filings/0000759944-25-000013.md) | [3.13](/filings/0000759944-26-000028.md) | [3.03](/filings/0000759944-26-000028.md) | [3.86](/filings/0000759944-26-000028.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cfg/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $3.42bn | 48,737,629 |  | Added +2,037,542 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.89bn | 26,906,653 |  | Added +41,814 |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $1.63bn | 23,269,185 |  | Reduced −4,634,869 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $1.55bn | 22,154,682 |  | Reduced −772,127 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $1.49bn | 21,241,311 |  | Added +978,979 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $1.44bn | 20,567,346 |  | Added +641,583 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $859.4m | 12,264,969 |  | Reduced −447,712 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $824.8m | 11,815,760 |  | Added +5,290 |
| [Ninety One UK Ltd](/funds/1418329.md) | 2026-06-30 | $550.2m | 7,851,457 |  | Added +1,083,233 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $534.4m | 7,626,834 |  | Added +286,189 |

## Recent filings

[All 1,588 filings](/companies/cfg/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 16:30 ET | [8-K](/filings/0001193125-26-441754.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-26-441754 |
| 2026-10-28 | 16:06 ET | [10-Q](/filings/0000759944-26-000213.md) | Quarterly report, period 2026-09-30 | 0000759944-26-000213 |
| 2026-10-16 | 06:34 ET | [8-K](/filings/0000759944-26-000206.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000759944-26-000206 |
| 2026-10-08 | 16:54 ET | [8-K](/filings/0000759944-26-000192.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000759944-26-000192 |
| 2026-08-03 | 16:38 ET | [10-Q](/filings/0000759944-26-000148.md) | Quarterly report, period 2026-06-30 | 0000759944-26-000148 |
| 2026-07-31 | 17:57 ET | [8-K](/filings/0001193125-26-326411.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-326411 |
| 2026-07-21 | 08:22 ET | [8-K](/filings/0000759944-26-000139.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000759944-26-000139 |
| 2026-07-16 | 06:32 ET | [8-K](/filings/0000759944-26-000133.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000759944-26-000133 |
| 2026-05-04 | 11:21 ET | [10-Q](/filings/0000759944-26-000101.md) | Quarterly report, period 2026-03-31 | 0000759944-26-000101 |
| 2026-04-24 | 16:10 ET | [8-K](/filings/0000759944-26-000073.md) | 5.07 Shareholder vote results | 0000759944-26-000073 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000759944-26-000028.md), filed Feb 12, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 759944
- Tickers: CFG, CFG-PE, CFG-PH, CFG-PI
- Exchange: NYSE
- SIC code: 6022 State Commercial Banks
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 16:39 ET. No prices; not investment advice.